Monday, April 29, 2024
HomeTagsMODULAR

MODULAR

Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major...

EPAM Debuts New Cloud-Powered Digital Clinical Trials Platform

Clinical trials are a key step to bringing new pharmaceutical drugs to market, but they are also faced with an increasing number of challenges,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics